Dr. Sandy Srinivas

Dr. Sandhya Srinivas, MD, is a nationally recognized medical oncologist specializing in genitourinary cancers, including kidney, bladder, and prostate malignancies. She serves as a Professor of Medicine (Oncology) at Stanford University School of Medicine and as Clinical Research Group Leader for the Genitourinary Oncology Program at the Stanford Cancer Institute. Dr. Srinivas earned her medical degree from Madras Medical College in India and completed her residency in internal medicine at Yale University. She pursued fellowship training in medical oncology at Stanford University, where she has remained a key leader in cancer care and research. She is board-certified in Internal Medicine and Medical Oncology.

Dr. Srinivas is widely known for her leadership in clinical trials and translational research for advanced and metastatic genitourinary cancers. Her work focuses on integrating immunotherapy, targeted agents, and novel drug combinations to improve outcomes for patients with renal cell carcinoma and urothelial cancers. She has served as principal investigator on numerous clinical studies and collaborates across national research networks to advance care standards. Her research has been published in leading peer-reviewed journals and contributes to evolving treatment algorithms in genitourinary oncology.

In addition to her clinical and research accomplishments, Dr. Srinivas is a respected educator and mentor at Stanford, training oncology fellows and junior faculty in evidence-based cancer care and clinical trial development. She is actively involved in national organizations, including the American Society of Clinical Oncology and the Southwest Oncology Group, where she helps shape future directions in urologic cancer treatment. Through her commitment to innovation, collaborative research, and academic leadership, Dr. Srinivas continues to drive progress in genitourinary oncology at Stanford and beyond.